China Pharma Holdings, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $78.5M
Liabilities Breakdown FY2016
Total Liabilities: $19.6M
Asset Breakdown
Total Assets: $78.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.7M | 3.4% |
| Accounts Receivable | $4.0M | 5.1% |
| Inventory | $7.3M | 9.3% |
| Property, Plant & Equipment | $25.0M | 31.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $534.7K | 0.7% |
| Other Assets | $39.0M | 49.7% |
Liabilities Breakdown
Total Liabilities: $19.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.1M | 15.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $16.6M | 84.4% |